Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-25

Clinical Trial Update: A Reduced 11-b-HSD Activity, a Novel Mechanism of Salt Sensitivity and Hypertension After Renal Allograft Donation? [NA]

View source ↗

Summary

Completed clinical trial investigating reduced 11-beta-HSD activity as a mechanism for salt sensitivity and hypertension following renal allograft donation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Renal Failure, Renal Transplantation | NA | Status: COMPLETED